My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie

Ritalin LA 40mg prolonged-release capsules

InfectoPharm Arzneimittel und Consilium GmbHPA1972/002/004

Main Information

Trade NameRitalin LA 40mg prolonged-release capsules

Active SubstancesMethylphenidate hydrochloride

Dosage FormProlonged-release capsule, hard

Licence HolderInfectoPharm Arzneimittel und Consilium GmbH

Licence NumberPA1972/002/004

Group Information

ATC CodeN06BA Centrally acting sympathomimetics
N06BA04 methylphenidate

Status

License statusAuthorised

Licence Issued11/07/2003

Legal statusProduct subject to prescription which may not be renewed (A)

Supply StatusSupply through pharmacies only

Advertising StatusAdvertising to healthcare professionals only

Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2). This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.

Marketing StatusMarketed